v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Income Statement [Abstract]        
Revenue
Operating expenses:        
Research and development expenses (including non-cash stock-based compensation expenses of $286, $358, $909 and $1,172, respectively) 1,326 1,055 3,686 3,929
General and administrative expenses (including non-cash stock-based compensation expenses of $380, $497, $1,218 and $1,727, respectively) 1,411 1,381 4,414 4,896
Total operating expenses 2,737 2,436 8,100 8,825
Loss from operations (2,737) (2,436) (8,100) (8,825)
Interest income 112 156 354 519
Net loss (2,625) (2,280) (7,746) (8,306)
Less: Net loss attributable to noncontrolling interest (19) (22) (59) (74)
Net loss attributable to common shareholders $ (2,606) $ (2,258) $ (7,687) $ (8,232)
Net loss per common share attributable to common shareholders:        
Basic $ (0.08) $ (0.07) $ (0.23) $ (0.25)
Diluted $ (0.08) $ (0.07) $ (0.23) $ (0.25)
Weighted average common shares outstanding:        
Basic 34,182 32,476 33,673 32,293
Diluted 34,182 32,476 33,673 32,293